NDC 29300-313 – Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride

Cetirizine Hydrochloride 5 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Film Coated, Extended Release · Oral

Human Otc Drug

Product NDC29300-313

Product details

Brand name
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Generic name
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler
Unichem Pharmaceuticals (USA), Inc.
Dosage form
Tablet, Film Coated, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210507
Marketed since
September 10, 2024
Listing expires
December 31, 2027
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cetirizine hydrochloride and Pseudoephedrine hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
29300-313-222 BLISTER PACK in 1 CARTON (29300-313-22) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (29300-313-61)Jan 1, 2025
29300-313-244 BLISTER PACK in 1 CARTON (29300-313-24) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (29300-313-61)Jan 1, 2025

Other Cetirizine hydrochloride and Pseudoephedrine hydrochloride products